FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

327235003: Daclizumab 25mg/5mL infusion concentrate (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    466806012 Daclizumab 25mg/5mL infusion concentrate en Synonym Active Only initial character case insensitive SNOMED CT core module
    1191388018 Daclizumab 25mg/5mL infusion concentrate (product) en Fully specified name Active Only initial character case insensitive SNOMED CT core module
    2164777019 Daclizumab 25mg/5 mL solution en Synonym Active Only initial character case insensitive SNOMED CT core module
    53210701000001111 Daclizumab 25mg/5ml solution for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Daclizumab 25mg/5mL infusion concentrate Is a Product containing daclizumab false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Is a Product containing daclizumab false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Has active ingredient Monoclonal antibody false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Has active ingredient Daclizumab false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Is a Product manufactured as parenteral dose form false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Has manufactured dose form Infusion concentrate false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Has manufactured dose form Solution for injection false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Has manufactured dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Has specific active ingredient Daclizumab false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Has dispensed dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5mL infusion concentrate Has manufactured dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Daclizumab 25mg/5mL infusion concentrate - product Is a False Daclizumab 25mg/5mL infusion concentrate Inferred relationship Existential restriction modifier
    Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Is a False Daclizumab 25mg/5mL infusion concentrate Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5ml solution for injection vials 3 vial Is pack of False Daclizumab 25mg/5mL infusion concentrate Inferred relationship Existential restriction modifier
    Daclizumab 25mg/5ml solution for injection vials 3 vial Has VMP False Daclizumab 25mg/5mL infusion concentrate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start